In this regard, it is significant that fibronectin inhibition is reported to exert cardioprotective effects through a significant reduction in cardiac fibrosis and adverse fibrotic remodeling in an ischemia/reperfusion injury model [4]. The gene discussed is FN1; the disease is fibrosis.